questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzofuranes
Benzofuranes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Intoxication
Tests toxicologiques
Analyse de sang
Analyse d'urine
Symptômes
Troubles neurologiques
Tests de dépistage
Benzofuranes
Historique médical
Exposition
Symptômes
5
Effets psychologiques
Anxiété
Éruptions cutanées
Démangeaisons
Système respiratoire
Irritation
Prévention
5
Prévention
Équipements de protection
Mesures de sécurité
Laboratoire
Gestion des déchets
Déchets dangereux
Traitements
5
Intoxication
Soins symptomatiques
Symptômes neurologiques
Médicaments
Soins d'urgence
Exposition
Décontamination
Absorption
Complications
5
Complications
Neurologiques
Maladies chroniques
Exposition prolongée
Effets à long terme
Troubles cognitifs
Reproduction
Effets néfastes
Suivi médical
Complications
Facteurs de risque
5
Travailleurs
Produits chimiques
Produits chimiques
Médicaments
Antécédents médicaux
Maladies respiratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Benzofuranes : Questions médicales les plus fréquentes",
"headline": "Benzofuranes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Benzofuranes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-05",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Benzofuranes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérobicycliques",
"url": "https://questionsmedicales.fr/mesh/D006574",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérobicycliques",
"code": {
"@type": "MedicalCode",
"code": "D006574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amiodarone",
"alternateName": "Amiodarone",
"url": "https://questionsmedicales.fr/mesh/D000638",
"about": {
"@type": "MedicalCondition",
"name": "Amiodarone",
"code": {
"@type": "MedicalCode",
"code": "D000638",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.075"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dronédarone",
"alternateName": "Dronedarone",
"url": "https://questionsmedicales.fr/mesh/D000077764",
"about": {
"@type": "MedicalCondition",
"name": "Dronédarone",
"code": {
"@type": "MedicalCode",
"code": "D000077764",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.075.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Benzbromarone",
"alternateName": "Benzbromarone",
"url": "https://questionsmedicales.fr/mesh/D001553",
"about": {
"@type": "MedicalCondition",
"name": "Benzbromarone",
"code": {
"@type": "MedicalCode",
"code": "D001553",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cantharidine",
"alternateName": "Cantharidin",
"url": "https://questionsmedicales.fr/mesh/D002193",
"about": {
"@type": "MedicalCondition",
"name": "Cantharidine",
"code": {
"@type": "MedicalCode",
"code": "D002193",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Citalopram",
"alternateName": "Citalopram",
"url": "https://questionsmedicales.fr/mesh/D015283",
"about": {
"@type": "MedicalCondition",
"name": "Citalopram",
"code": {
"@type": "MedicalCode",
"code": "D015283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.187"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Escitalopram",
"alternateName": "Escitalopram",
"url": "https://questionsmedicales.fr/mesh/D000089983",
"about": {
"@type": "MedicalCondition",
"name": "Escitalopram",
"code": {
"@type": "MedicalCode",
"code": "D000089983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.203"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fura-2",
"alternateName": "Fura-2",
"url": "https://questionsmedicales.fr/mesh/D016257",
"about": {
"@type": "MedicalCondition",
"name": "Fura-2",
"code": {
"@type": "MedicalCode",
"code": "D016257",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Griséofulvine",
"alternateName": "Griseofulvin",
"url": "https://questionsmedicales.fr/mesh/D006118",
"about": {
"@type": "MedicalCondition",
"name": "Griséofulvine",
"code": {
"@type": "MedicalCode",
"code": "D006118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.127.275"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Benzofuranes",
"alternateName": "Benzofurans",
"code": {
"@type": "MedicalCode",
"code": "D001572",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zhi Xu",
"url": "https://questionsmedicales.fr/author/Zhi%20Xu",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China."
}
},
{
"@type": "Person",
"name": "Wei Zhou",
"url": "https://questionsmedicales.fr/author/Wei%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China."
}
},
{
"@type": "Person",
"name": "Ashraf A Abbas",
"url": "https://questionsmedicales.fr/author/Ashraf%20A%20Abbas",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602."
}
},
{
"@type": "Person",
"name": "Kamal M Dawood",
"url": "https://questionsmedicales.fr/author/Kamal%20M%20Dawood",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602."
}
},
{
"@type": "Person",
"name": "Giovanni Luca Beretta",
"url": "https://questionsmedicales.fr/author/Giovanni%20Luca%20Beretta",
"affiliation": {
"@type": "Organization",
"name": "Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Understanding triage assessment of acuity by emergency nurses at initial adult patient presentation: A qualitative systematic review.",
"datePublished": "2023-09-14",
"url": "https://questionsmedicales.fr/article/37716173",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ienj.2023.101334"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association between initial presenting level of consciousness and patient acuity - A potential application for secondary triage in emergency ambulance calls.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36496330",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.auec.2022.11.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Use of a Large Language Model to Assess Clinical Acuity of Adults in the Emergency Department.",
"datePublished": "2024-05-01",
"url": "https://questionsmedicales.fr/article/38713466",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.8895"
}
},
{
"@type": "ScholarlyArticle",
"name": "Redirection of low-acuity emergency department patients to nearby medical clinics using an electronic medical support system: effects on emergency department performance indicators.",
"datePublished": "2024-09-13",
"url": "https://questionsmedicales.fr/article/39272018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12873-024-01080-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "\"I do not know the advantages of having a general practitioner\" - a qualitative study exploring the views of low-acuity emergency patients without a regular general practitioner toward primary care.",
"datePublished": "2024-05-15",
"url": "https://questionsmedicales.fr/article/38750500",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-024-10977-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzofuranes",
"item": "https://questionsmedicales.fr/mesh/D001572"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Benzofuranes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Benzofuranes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Benzofuranes",
"description": "Comment diagnostiquer une intoxication aux benzofuranes ?\nQuels tests sont utilisés pour détecter les benzofuranes ?\nQuels symptômes indiquent une exposition aux benzofuranes ?\nLes benzofuranes sont-ils visibles sur des tests standards ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Patient+Acuity#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Benzofuranes",
"description": "Quels sont les symptômes courants des benzofuranes ?\nLes benzofuranes provoquent-ils des effets psychologiques ?\nY a-t-il des symptômes cutanés associés aux benzofuranes ?\nLes benzofuranes affectent-ils le système respiratoire ?\nLes symptômes varient-ils selon la dose de benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Patient+Acuity#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Benzofuranes",
"description": "Comment prévenir l'exposition aux benzofuranes ?\nLes travailleurs doivent-ils être formés sur les benzofuranes ?\nQuelles mesures de sécurité sont recommandées en laboratoire ?\nLes benzofuranes sont-ils réglementés ?\nComment gérer les déchets contenant des benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Patient+Acuity#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Benzofuranes",
"description": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?\nDes antidotes existent-ils pour les benzofuranes ?\nComment traiter les symptômes neurologiques causés par les benzofuranes ?\nLes soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?\nLa décontamination est-elle nécessaire après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Patient+Acuity#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Benzofuranes",
"description": "Quelles complications peuvent survenir après exposition aux benzofuranes ?\nLes benzofuranes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des benzofuranes ?\nLes benzofuranes peuvent-ils affecter la reproduction ?\nComment surveiller les complications liées aux benzofuranes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Patient+Acuity#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Benzofuranes",
"description": "Qui est à risque d'exposition aux benzofuranes ?\nLes benzofuranes sont-ils présents dans des produits courants ?\nL'âge influence-t-il la sensibilité aux benzofuranes ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes benzofuranes affectent-ils différemment les sexes ?",
"url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Patient+Acuity#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux benzofuranes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et les tests toxicologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les benzofuranes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux benzofuranes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles neurologiques, des nausées et des palpitations."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils visibles sur des tests standards ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, des tests spécifiques sont nécessaires pour détecter les benzofuranes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux benzofuranes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des benzofuranes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des maux de tête et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Les benzofuranes provoquent-ils des effets psychologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer de l'anxiété, des hallucinations et des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés aux benzofuranes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées et des démangeaisons peuvent survenir après exposition."
}
},
{
"@type": "Question",
"name": "Les benzofuranes affectent-ils le système respiratoire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent provoquer des difficultés respiratoires et une irritation des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose de benzofuranes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux benzofuranes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés sur les benzofuranes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité sont recommandées en laboratoire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des hottes, des gants et des lunettes de protection lors de la manipulation."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils réglementés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation est souvent réglementée en raison de leur toxicité potentielle."
}
},
{
"@type": "Question",
"name": "Comment gérer les déchets contenant des benzofuranes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déchets doivent être éliminés selon les protocoles de gestion des déchets dangereux."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'élimination de l'exposition et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les benzofuranes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antidote spécifique pour les benzofuranes."
}
},
{
"@type": "Question",
"name": "Comment traiter les symptômes neurologiques causés par les benzofuranes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour gérer les symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins d'urgence peuvent être nécessaires en cas d'exposition sévère."
}
},
{
"@type": "Question",
"name": "La décontamination est-elle nécessaire après exposition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la décontamination est essentielle pour réduire l'absorption des benzofuranes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition aux benzofuranes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, respiratoires et dermatologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les benzofuranes peuvent-ils causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut augmenter le risque de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme des benzofuranes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les benzofuranes peuvent-ils affecter la reproduction ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications liées aux benzofuranes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier est recommandé pour détecter les complications précoces."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'exposition aux benzofuranes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque."
}
},
{
"@type": "Question",
"name": "Les benzofuranes sont-ils présents dans des produits courants ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être présents dans certains produits chimiques et médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité aux benzofuranes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou neurologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les benzofuranes affectent-ils différemment les sexes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que les effets peuvent varier entre les sexes, mais les données sont limitées."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Food, Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Celoria 2, 20133 Milan, Italy.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Guwahati Assam 781039 India span@iitg.ac.in https://www.iitg.ac.in/span/.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemical Technology Mumbai IOC Odisha Campus Bhubaneswar Bhubaneswar 751013 India.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Chemical Technology Mumbai IOC Odisha Campus Bhubaneswar Bhubaneswar 751013 India.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Guwahati Assam 781039 India span@iitg.ac.in https://www.iitg.ac.in/span/.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou 510006, China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Central laboratory, The NO.1 Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming 650021, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
School of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, P.R. China.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Institute of Organic Chemistry of Polish Academy of Sciences, Kasprzaka 44/52, 01-224, Warsaw, Poland.
Publications dans "Benzofuranes" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Government College University Faisalabad, 38000 Faisalabad, Pakistan.
Publications dans "Benzofuranes" :
Nurses make complex triage decisions within emergency departments, which significantly affect patient outcomes. Understanding how nurses make these decisions and why they deviate from triage algorithm...
This qualitative systematic review aimed to understand decision-making processes emergency nurses use to make acuity decisions during triage assessment at initial patient presentation....
Medline, CINAHL and Academic Search Complete were systematically searched to 15th December 2022. Data were analysed using thematic synthesis. Established themes were reviewed with GRADE-CERQual to eva...
28 studies were included in the review. Data analysis uncovered three superordinate themes of holistic reasoning, situational awareness, and informed decision-making. The findings show nurses value ho...
This review presents new perspectives on nurses' decision-making processes about patient's acuity. Nurses holistically gather information about patients before translating that information into acuity...
Conscious state assessment is important for the triage of emergency patients. In this study, we measured the association between ambulance patients' conscious state and high versus lower acuity, with ...
Data were analysed from one year of emergency ambulance incidents in Perth, Western Australia. Patient conscious state at the time of paramedic arrival was compared to acuity (based on paramedic asses...
The proportion of high acuity patients increased with each step across the consciousness scale. Applying conscious state as a binary predictor of acuity, the largest increases occurred moving the thre...
Based on these proportions of high acuity patients, it is reasonable to consider patients with any altered conscious state a high priority. The value of conscious state assessment for predicting acuit...
The introduction of large language models (LLMs), such as Generative Pre-trained Transformer 4 (GPT-4; OpenAI), has generated significant interest in health care, yet studies evaluating their performa...
To determine whether an LLM can accurately assess clinical acuity in the emergency department (ED)....
This cross-sectional study identified all adult ED visits from January 1, 2012, to January 17, 2023, at the University of California, San Francisco, with a documented Emergency Severity Index (ESI) ac...
The potential of the LLM to classify acuity levels of patients in the ED based on the ESI across 10 000 patient pairs. Using deidentified clinical text, the LLM was queried to identify the patient wit...
Accuracy score was calculated to evaluate the performance of both LLMs across the 10 000-pair sample. A 500-pair subsample was manually classified by a physician reviewer to compare performance betwee...
From a total of 251 401 adult ED visits, a balanced sample of 10 000 patient pairs was created wherein each pair comprised patients with disparate ESI acuity scores. Across this sample, the LLM correc...
In this cross-sectional study of 10 000 pairs of ED visits, the LLM accurately identified the patient with higher acuity when given pairs of presenting histories extracted from patients' first ED docu...
Overcrowded emergency departments (EDs) are associated with higher morbidity and mortality and suboptimal quality-of-care. Most ED flow management strategies focus on early identification and redirect...
We performed a retrospective observational study in the ED of a Canadian tertiary trauma center where a redirection process for low-acuity patients was implemented. The process was based on a clinical...
Of 242,972 ED attendees over the study period, 9546 (8% of 121,116 post-intervention patients) were redirected to a nearby primary medical clinic. After the redirection process was implemented, length...
Implementing a redirection process for low-acuity ED patients based on a clinical support system was associated with improvements in two of four ED performance indicators....
Emergency departments (ED) worldwide have to cope with rising patient numbers. Low-acuity consulters who could receive a more suitable treatment in primary care (PC) increase caseloads, and lack of PC...
Qualitative semi-structured telephone interviews were conducted with 32 low-acuity ED consulters with no self-reported attachment to a GP. Participants were recruited from three EDs in the city center...
Interviewed patients reported heterogeneous factors contributing to their PC utilization behavior and underlying views and experiences. Participants most prominently voiced a rare need for medical ser...
Understanding reasons of low-acuity ED patients for GP non-utilization can play an important role in the design and implementation of patient-centered care interventions for PC integration. Increasing...
German Clinical Trials Register: DRKS00023480; date: 2020/11/27....
To evaluate the extent to which patient-users reporting symptoms of five severe/acute conditions requiring emergency care to an AI-based virtual triage (VT) engine had no intention to get such care, a...
A dataset of 3,022,882 VT interviews conducted over 16 months was evaluated to quantify and describe patient-users reporting symptoms of five potentially life-threatening conditions whose pre-triage h...
Healthcare intent data was obtained for 12,101 VT patient-user interviews. Across all five conditions a weighted mean of 38.5% of individuals whose VT indicated a condition requiring emergency care ha...
AI-based VT may offer a vehicle for early detection and care acuity alignment of severe evolving pathology by engaging patients who believe their symptoms are not serious, and for accelerating care re...
The leading diagnostic tool in modern ophthalmology, Optical Coherence Tomography (OCT), is not yet able to establish the evolution of retinal diseases. Our task is to forecast the progression of reti...
The purpose of this study was to predict visual acuity (VA) 90 days after presentation for patients with microbial keratitis (MK) from data at the initial clinical ophthalmic encounter....
Patients with MK were identified in the electronic health record between August 2012 and February 2021. Random forest (RF) models were used to predict 90-day VA < 20/40 [visual impairment (VI)]. Predi...
One thousand seven hundred ninety-one patients were identified. The presenting logMAR VA was on average 0.86 (Snellen equivalent and standard deviation = 20/144 ± 12.6 lines) in the affected or worse ...
RF modeling yielded good sensitivity and specificity to predict VI at 90 days which could guide clinicians about the risk of poor vision outcomes for patients with MK....
To determine factors influencing patient satisfaction scores in recipients of refractive surgery....
In this prospective survey-based study, patients who had refractive surgery at an outpatient refractive clinic completed a survey of selected questions from the Press Ganey survey and the National Eye...
Fifty-three patients were recruited over a 3-year period. Most were male (55%) and middle aged (mean age: 34 years). Eleven percent underwent photorefractive keratectomy surgery and the rest had laser...
This study found persistent high patient satisfaction score across a variation of characteristics, suggesting that optimal scores are mainstay after refractive surgery procedures with excellent visual...
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease characterised by decline in lung function. We evaluated trajectories of forced vital capacity (FVC) and diffusi...
Patients with IPF that was diagnosed or confirmed at the enrolling centre in the previous 6 months were enrolled into the IPF-PRO Registry between June 2014 and October 2018. Patients were followed pr...
Of 1002 patients in the registry, 941 had ≥ 1 FVC and/or DLco measurement after enrolment. The median (Q1, Q3) follow-up period was 35.1 (18.9, 47.2) months. Overall, mean estimated declines in FVC an...
Data from the IPF-PRO Registry suggest a constant rate of decline in lung function over a prolonged period, supporting the inexorably progressive nature of IPF. A graphical abstract summarising the da...
NCT01915511....